• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1550300-15
Device Problems Difficult or Delayed Positioning (1157); Defective Device (2588)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/29/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for analysis.The investigation determined the reported difficulty to position appears to be related to circumstances of the procedure as it is likely the identified cardiac movement caused the reported visibility issues and subsequent difficulty to position.Additionally, the investigation was unable to determine a conclusive cause for the reported material deformation (stent shortening).A review of the lot history record and complaint history of the reported device could not be conducted because the lot number was not provided.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Event Description
It was reported that this was a percutaneous intervention to treat a heavily calcified lesion in the left anterior descending (lad) to left circumflex coronary artery bifurcation site.Reportedly, the procedure had a lot of cardiac drift and imaging was difficult due the cardiac motion.Following atherectomy, the 3.0x15mm xience sierra rx stent delivery system advanced to the ostium lad lesion site without any issues and the stent was deployed.Although there was no issue with deployment, the implanted stent did not appear to be deployed in the intended area due to the amount of proximal and distal drift attributed to the patient's natural cardiac movement.Post-dilatation was performed as planned by using an unspecified 3.25x12mm balloon dilatation catheter.Following post-dilatation, imaging revealed that the stent was now at the initially intended deployment area at the lad ostium, and it was the opinion of the physician that the stent length consequently shortened and fit within the intended area.No further treatment was provided.There were no adverse patient effects and there was no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key8166692
MDR Text Key130489600
Report Number2024168-2018-09728
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227257
UDI-Public08717648227257
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 12/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1550300-15
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/29/2018
Initial Date FDA Received12/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-